Cialis (previously known as IC351) was first synthesised in 1990 in the ICOS Corporation, a Washington-based research company. In 1998, pharmaceutical company Eli Lilly joined the ICOS Corporation to expand the marketing venture of IC351, which was recognized to improve erectile function. In November 2003, the U.S. Food and Drug Administration (FDA) approved Cialis for the treatment of ED.

Lilly’s patent expired in 2020. This allowed for legal production of generic Cialis, commonly known as tadalafil. Generics have the huge benefit of being a lot cheaper.

Read more

Getting ED treatment is easy with telemedicine.

Feel young and confident with a full head of hair.

Let’s fix your
PE today.

Prioritise Your Health in 3 Simple Steps

*MOH requires all HCI-registered telemedicine clinics to perform a single video consultation

Share This Story, Choose Your Platform!